Navigation Links
Jazz Pharmaceuticals Announces Second Quarter 2014 Financial Results And Updated Guidance
Date:8/5/2014

ore income tax provision for the respective three-and six-month periods (for the six months ended June 30, 2014, on a non-GAAP adjusted basis only).(h)

Net of adjustments (e) and (f) for the respective three-month period.(i)

Adjustments for amount attributable to noncontrolling interests for the respective three-and six-month period.(j)

Net of adjustments (h) and (i) for the respective three-month period. (k)

Acquisition accounting inventory fair value step-up adjustments of $10,477 and $2,631, share-based compensation expense of $1,465 and $1,197, depreciation expense of $340 and $0, restructuring charges of $0 and $68 and transaction and integration costs of $0 and $33 for the six months ended June 30, 2014 and 2013, respectively. (l)

Share-based compensation expense of $25,217 and $16,544, transaction and integration costs of $22,394 and $1,645, depreciation expense of $2,399 and $1,130, change in fair value of contingent consideration of $0 and $7,900, and restructuring charges of $0 and $1,389 for six months ended June 30, 2014 and 2013, respectively. (m)

Share-based compensation expense of $5,685 and $2,522, depreciation expense of $430 and $40, transaction and integration costs of $246 and $55 for six months ended June 30, 2014 and 2013, respectively. (n)

Sum of adjustments (k), (l), (m) and (d) plus the adjustments for acquired in-process research and development, amortization and impairment of intangible assets and loss on extinguishment and modification of debt for the respective six-month period.(o)

The GAAP effective tax rate for the six months ended June 30, 2014 is not applicable because there was a loss before income tax provision during the period. After adjusting the loss before income tax provision by excluding an upfront fee and milestone payment of $127,000 for JZP-110, we would have had income before income tax provision of $113,324, resulting in an effective tax rate of 32.
'/>"/>

SOURCE Jazz Pharmaceuticals plc
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine technology :

1. Cumberland Pharmaceuticals Reports Second Quarter 2014 Financial Results
2. Avanir Pharmaceuticals to Participate in Two Conferences in August
3. Heritage Pharmaceuticals Inc. Signs Exclusive Development Supply & Distribution Agreement with Dexcel Ltd.
4. Genoa Pharmaceuticals Receives Orphan-Drug Designation for Pirfenidone in the Inhaled Treatment of Idiopathic Pulmonary Fibrosis (IPF)
5. Jazz Pharmaceuticals Announces Participation at Canaccord Genuity Conference on August 13
6. Lemelson Capital Management Further Increases Short Position in Ligand Pharmaceuticals (NASDAQ: LGND), Updates LGND Research Report with New Material Information
7. Rock Creek Pharmaceuticals to Present at the Annual BioPharm America International Partnering Conference
8. Pharmaceuticals Learning the Language of the New Healthcare Landscape
9. Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit
10. Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy
11. Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... , Nov. 24, 2014  Surgical Theater, LLC, announced ... November 24 th opening of Europe,s ... Neurologico Nazionale "C. Besta." The SuRgical Planner (SRP) and ... at the event for their 3D navigation and augmented ... Joshua Bederson , Professor and Chair, Department of Neurosurgery ...
(Date:11/24/2014)... Nov. 24, 2014  Inovio Pharmaceuticals, Inc. (NASDAQ: ... , President and CEO of Inovio Pharmaceuticals, will be joined ... ring the Nasdaq Opening Bell tomorrow, Tuesday November 25, 2014, ... th listing on the Nasdaq Global Select Market.  ... said, "We are honored to ring the Nasdaq Opening Bell ...
(Date:11/22/2014)... Nov. 21, 2014  CytoSorbents Corporation (OTCQB: CTSO), ... Union approved CytoSorb® cytokine adsorber to treat critically-ill ... Beacon of Light Award at last night,s New ... Dr. Phillip Chan , Chief Executive ... to be recognized by the New Jersey Tech ...
Breaking Medicine Technology:Surgical Theater's Technology to be Showcased at the Opening of the Besta NeuroSim Center in Milan, Italy 2Surgical Theater's Technology to be Showcased at the Opening of the Besta NeuroSim Center in Milan, Italy 3Inovio Pharmaceuticals to Ring Opening Bell Nov 25th on the Nasdaq Stock Market 2Inovio Pharmaceuticals to Ring Opening Bell Nov 25th on the Nasdaq Stock Market 3CytoSorbents Wins Beacon of Light Award 2CytoSorbents Wins Beacon of Light Award 3CytoSorbents Wins Beacon of Light Award 4
... budget pressures, countries around the world are making ... lure the biopharmaceutical research sector away from the ... Technology Partnership Practice. The study, commissioned ... (PhRMA), further found that while many countries are ...
...   Accuray Incorporated (Nasdaq: ARAY ), ... of Richard Pettingill, LFACHE as a member of the ... Richard Pettingill,s career as a healthcare executive ... variety of prominent organizations. Most recently, Pettingill, who is ...
Cached Medicine Technology:New Study Details Foreign Efforts To Lure Biopharmaceutical Companies 2New Study Details Foreign Efforts To Lure Biopharmaceutical Companies 3Accuray Appoints Richard Pettingill, LFACHE to Board of Directors 2Accuray Appoints Richard Pettingill, LFACHE to Board of Directors 3
(Date:11/23/2014)... -- Close friends have more influence on teens, alcohol ... study says. "We,ve known for a long ... individual alcohol use, but there are no common studies ... friend group,s influence on those decisions," Jonathon Beckmeyer, an ... said in a university news release. Beckmeyer analyzed ...
(Date:11/23/2014)... Locks-Magnetic.com, a notable magnetic locks maker, ... the new products are available at low rates up ... proud of the new emergency doors. The emergency door ... can choose from several colors. All of the products ... door release is not as easy as many people ...
(Date:11/23/2014)... show thanks to new and old customers, iFitDress.com has ... for weddings. Customers who need custom outfits can talk ... dress manufacturer, and it is among the ones which have ... long time. The CEO of this company says, "iFitDress.com is ... buy not only a beautiful dress, but also a piece ...
(Date:11/23/2014)... York, NY (PRWEB) November 23, 2014 ... the past month in a federal litigation involving Byetta ... similar diabetes medications, Bernstein Liebhard LLP reports. , ... 566 claims over a class of Type 2 diabetes ... filed in the U.S. District Court, Southern District of ...
(Date:11/23/2014)... 23, 2014 Asher Milgrom, is ... & Wellness was recently featured on International ... president and CEO of American Medical Aesthetics & Wellness, ... received a full scholarship to attend an M.D./Ph.D program ... at the University of Chicago, where his field of ...
Breaking Medicine News(10 mins):Health News:Close Friends May Be Key to Teens' Drinking 2Health News:iFitDress.com: Wonderful White Evening Dresses Now Available 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 3Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 4Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 2Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 3Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 4
... FRIDAY, March 25 (HealthDay News) -- Even very young ... negative emotions toward them, researchers confirm. The new ... harmless, but stress-inducing, situations, such as causing them to ... saliva samples were taken from the children to measure ...
... FRIDAY, March 25 (HealthDay News) -- Most people want to ... through with healthy lifestyle habits, finds a new survey. ... found that 93.3 percent of respondents believe they are more ... said their doctor was more responsible and 2.3 percent didn,t ...
... Reporter , FRIDAY, March 25 (HealthDay News) -- Teen superstar Nick ... ago his body was wasting away. Even at 13, Jonas knew ... something was type 1 diabetes, and though it,s a disease Jonas ... because he spends a lot of time every day taking care ...
... Food and Drug Administration today approved the use of ipilimumab ... the first drug approved for metastatic, or advanced, melanoma is ... a new class of drugs that has been shown to ... a fatal disease, and hopefully, this will lead to the ...
... York, NY, Mar. 25, 2011 The U.S. Food and ... treatment for advanced melanoma, the deadliest and most difficult-to-treat form ... is the first treatment of any kind ever shown in ... improve overall survival in patients with metastatic melanoma who no ...
... News) -- Seniors who suffer elder abuse are more likely ... and to abuse drugs or alcohol, new research indicates. ... Chicago-area trauma units and compared 41 cases of elder abuse ... group) who were treated between 1999 and 2006. The ...
Cached Medicine News:Health News:Study Highlights How Moms' Depression, Anger Stresses Kids 2Health News:Nick Jonas Lives Large, Despite Diabetes 2Health News:Nick Jonas Lives Large, Despite Diabetes 3Health News:FDA approves new drug for advanced melanoma 2Health News:FDA approves ipilimumab, an immunotherapy, to treat metastatic melanoma 2Health News:FDA approves ipilimumab, an immunotherapy, to treat metastatic melanoma 3Health News:FDA approves ipilimumab, an immunotherapy, to treat metastatic melanoma 4Health News:Alcohol May Play Dual Role in Some Cases of Elder Abuse 2
... a rapid qualitative test for detection of ... serum samples. It can be used as ... infarction and can be useful to assess ... non-cardiac angina (e.g. gastric pain, strained chest ...
...
...
...
Medicine Products: